Ur Rahman Muhammad Saif, Cao Jiang
Muhammad Saif Ur Rahman, Jiang Cao, Clinical Research Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China.
World J Gastroenterol. 2016 Feb 28;22(8):2475-82. doi: 10.3748/wjg.v22.i8.2475.
Worldwide, gastric cancer is one of the most common malignancies with high mortality. Various aspects of the development and progression of gastric cancer continue to be extensively investigated in order to further our understanding and provide more effective means for the prevention, diagnosis, and treatment of the disease. Estrogen receptors (ERs) are steroid hormone receptors that regulate cellular activities in many physiological and pathological processes in different tissues. There are two distinct forms of ERs, namely ERα and ERβ, with several alternative-splicing isoforms for each. They show distinct tissue distribution patterns and exert different biological functions. Dysregulation of ERs has been found to be associated closely with many diseases, including cancer. A number of studies have been conducted to investigate the role of ERs in gastric cancer, the possible mechanisms underlying these roles, and the clinical relevance of deregulated ERs in gastric cancer patients. To date, inconsistent associations of different ERs with gastric cancer have been reported. These inconsistencies may be caused by variations in in vitro cell models and clinical samples, including assay conditions and protocols with regard to different forms of ERs. Given the potential of the deregulated ERs as diagnostic/prognostic markers or therapeutic targets for gastric cancer, it will be important to identify/confirm the association of each ER isoform with gastric cancer, to determine the specific roles and interactions that these individual ER isoforms play under specific conditions in the development and/or progression of gastric cancer, and to elucidate precisely these mechanisms. In this review, we summarize the achievements from early ER studies in gastric cancer to the most up-to-date discoveries, with an effort to provide a comprehensive understanding of the role of ERs roles in gastric cancer and its possible mechanisms. Furthermore, we propose directions for future investigations.
在全球范围内,胃癌是最常见且死亡率高的恶性肿瘤之一。为了增进我们的理解并提供更有效的胃癌预防、诊断和治疗手段,胃癌发生发展的各个方面仍在持续进行广泛研究。雌激素受体(ERs)是类固醇激素受体,可调节不同组织中许多生理和病理过程的细胞活动。ERs有两种不同形式,即ERα和ERβ,每种又有几种可变剪接异构体。它们表现出不同的组织分布模式并发挥不同的生物学功能。已发现ERs失调与包括癌症在内的许多疾病密切相关。已经进行了多项研究来探讨ERs在胃癌中的作用、这些作用潜在的机制以及ERs失调在胃癌患者中的临床意义。迄今为止,已报道不同ERs与胃癌的关联不一致。这些不一致可能是由体外细胞模型和临床样本的差异引起的,包括针对不同形式ERs的检测条件和方案。鉴于失调的ERs作为胃癌诊断/预后标志物或治疗靶点的潜力,确定/确认每种ER异构体与胃癌的关联、确定这些个体ER异构体在胃癌发生和/或发展的特定条件下所起的具体作用和相互作用以及精确阐明这些机制将非常重要。在本综述中,我们总结了从早期ERs在胃癌研究中的成果到最新发现,努力全面了解ERs在胃癌中的作用及其可能机制。此外,我们还提出了未来研究的方向。